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Abstract One of the most important issues in orthopaedic
surgery is the loss of bone resulting from trauma,
infections, tumours or congenital deficiency. In view of
the hypothetical future application of mesenchymal stem
cells isolated from human adipose tissue in regenerative
medicine, we have analysed and characterized adipose-
derived stem cells (ASCs) isolated from adipose tissue of
rat, rabbit and pig. We have compared their in vitro
osteogenic differentiation abilities for exploitation in the
repair of critical osteochondral defects in autologous pre-
clinical models. The number of pluripotent cells per
millilitre of adipose tissue is variable and the yield of
rabbit ASCs is lower than that in rat and pig. However, all
ASCs populations show both a stable doubling time during
culture and a marked clonogenic ability. After exposure to
osteogenic stimuli, ASCs from rat, rabbit and pig exhibit a
significant increase in the expression of osteogenic markers
such as alkaline phosphatase, extracellular calcium deposi-
tion, osteocalcin and osteonectin. However, differences
have been observed depending on the animal species and/
or differentiation period. Rabbit and porcine ASCs have
been differentiated on granules of clinical grade hydroxy-
apatite (HA) towards osteoblast-like cells. These cells grow
and adhere to the scaffold, with no inhibitory effect of HA
during osteo-differentiation. Such in vitro studies are
necessary in order to select suitable pre-clinical models to
validate the use of autologous ASCs, alone or in association
with proper biomaterials, for the repair of critical bone
defects.
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Introduction
Research on mesenchymal stem cells has greatly advanced
during the recent past. These adult pluripotent stem cells
play a key role in maintaining the homeostasis of their
resident tissue and are able to differentiate into cellular
lineages belonging to the mesodermic layer (Caplan 1994)
and to transdifferentiate into neurons, hepatocytes and β-
islet cells (Jiang et al. 2002; Baksh et al. 2004; Chen et al.
2004).
Autologous mesenchymal stem cells isolated from
bone marrow (BMSCs, bone marrow stromal cells)
have previously been successfully used for osteo-
regeneration in patients with critical bone defects
(Quarto et al. 2001; Kitoh et al. 2004; Funk et al. 2007;
Jäger et al. 2009), whereas the use of autologous adipose-
derived stem cells (ASCs) to promote bone healing and
regeneration has been reported in just a few cases. For
instance, Lendeckel et al. (2004) have shown that these
cells repair calvarial bone defects in a 7-year-old child
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and, recently, Mesimäki et al. (2009) have reported the
first case of a microvascular custom-made ectopic bone
flap developed by using autologous ASCs and reim-
planted in a patient with a hemi-maxillectomy. ASCs with
their high multi-differentiative potential (Zuk et al. 2002;
De Ugarte et al. 2003; Rigotti et al. 2007; de Girolamo et
al. 2007, 2008; Bunnell et al. 2008) and their reduced
immunogenicity (Le Blanc et al. 2003; Barry 2003;
Majumdar et al. 2003) can be considered excellent
candidates for applications of regenerative medicine.
Furthermore, ASCs can be easily obtained from adipose
tissue with a more abundant cellular yield than BMSCs
(Nöth et al. 2002).
Autologous human ASCs (hASCs) have previously
been used with success to improve the lipotransfer
technique (Matsumoto et al. 2006), to heal ischaemic
lesions in patients who have undergone radiotherapy
(Rigotti et al. 2007), to treat facial lipoatrophy (Yoshimura
et al. 2008a) and for cosmetic breast augmentation
(Yoshimura et al. 2008b). This improvement might be
explained on the basis that ASCs are able either to
differentiate or to recruit resident cells, when implanted
in the physiological microenvironment. Recently, Cai et
al. (2009) have demonstrated that hASCs are able to
preserve heart function and augment local angiogenesis
following their administration in the context of myocardial
infarction in athymic rats.
We have previously characterized hASCs and shown
their in vitro differentiative potential into osteogenic,
chondrogenic and adipogenic lineages (de Girolamo et al.
2007, 2008). We have loaded hASCs onto various types of
scaffold to test their osteoinductive features and have
observed that these cells are sensitive to the effect of the
three-dimensional (3D) environment. Other authors have
demonstrated that ASCs can be isolated from the adipose
tissue of various animals such as the rat (Tholpady et al.
2003; Kingham et al. 2007; Yoshimura et al. 2007), rabbit
(Peptan et al. 2006; Torres et al. 2007), pig (Qu et al. 2007)
and horse (Vidal et al. 2007).
Moreover, various ASCs-based pre-clinical models have
been reported in bone tissue engineering. Osteoinduced
ASCs loaded on specific scaffolds exhibit a great healing
potential when implanted in rabbit and rat calvarial defects
(Dudas et al. 2006; Yoon et al. 2007) and, recently, Tobita
et al. (2008) have demonstrated, in rats, that ASCs mixed
with platelet-rich plasma induce periodontal ligament-like
and alveolar bone regeneration.
In this work, we have isolated ASCs from small,
medium and large animals, such as rats (rASCs), rabbits
(rbASCs) and pigs (pASCs). We have compared the
features of these cells in the undifferentiated state and their
ability to differentiate in vitro into cells of the osteogenic
lineage. The behavior of ASCs seeded on hydroxyapatite
(HA), a biomaterial used for some orthopaedic applications,
has also been evaluated.
Materials and methods
Harvesting of adipose tissue and isolation and culture
of ASCs
ASCs were isolated from adipose tissues harvested from
various areas: inguinal and perirenal regions from rat,
interscapular site of rabbit and caudal area from pig.
rbASCs were purified from interscapular adipose tissue
of adult New Zealand White rabbits (Torres et al. 2007)
killed by intramuscular administration of an overdose
(5 mg/kg) of a solution of 50 mg/ml sodium pentothal.
Primary cultures of the stromal vascular fraction (SVF)
were established as previously described with minor
modifications (Peptan et al. 2006). Adipose tissue was
finely minced and washed with phosphate-buffered saline
(PBS) containing 3× P/S (50 U/ml penicillin and 50 μg/ml
streptomycin; Sigma-Aldrich, Milan, Italy) and centrifuged
at 1200g for 2 min to remove erythrocytes and cellular
debris. Samples were then digested in a shaking water bath
for 60 min at 37°C by 0.1% type I collagenase (Worthing-
ton, Lakewood, N.J., USA) in PBS supplemented with 3×
P/S. After digestion, the collagenase I was neutralized by
adding an equal volume of DMEM (Sigma-Aldrich)
supplemented with 10% FBS (fetal bovine serum; Sigma-
Aldrich), 50 U/ml penicillin, 50 μg/ml streptomycin and
2 mM L-glutamine (Sigma-Aldrich). The samples were
centrifuged for 10 min at 1200g to separate the SVF from
adipocytes, cellular debris and undigested tissue. The SVF
was filtered through sterile medicinal lint and the pellet was
resuspended in control medium (CTRL). Cell number and
viability were determined by trypan-blue exclusion.
The same protocol was used to isolate mesenchymal
stem cells from pig caudal adipose tissue (Qu et al. 2007).
ASCs from Sprague-Dawley rats were isolated as
previously described with minor modifications (Tholpady
et al. 2003; Kingham et al. 2007; Yoshimura et al. 2007).
Adipose tissue was collected from both inguinal and
perirenal regions. The minced tissue was digested with
0.075% collagenase type I at 37°C for 45 min and then
centrifuged for 10 min at 350g.
ASCs derived from the SVF were plated in control
medium at a density of 105cells/cm2 and maintained at
37°C in a humidified atmosphere with 5% CO2. After
48-72 h, non-adherent cells were discarded by washing
with PBS. During all the period of culture, growth medium
was changed three times a week.
After reaching 80%-90% of confluence, cells were
detached by incubation with 0.5% trypsin/0.2% EDTA
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(Sigma-Aldrich). ASCs were plated at a density of 5×103
cells/cm2 for further expansion and experiments.
MTT cell proliferation assay
From passage 1 to 4 in culture, ASCs were trypsinized and
plated at a density of 5×103cells/cm2 in control medium.
ASCs viability was monitored at various time points (1, 6, 10
or 14 days) by addition, to the culture medium, of MTT (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide;
Sigma-Aldrich) at a final concentration of 0.5 mg/ml and
further incubation for 4 h at 37°C. The resulting formazan
precipitate was then solubilized by using 100% dimethyl-
sulphoxide and the absorbance was read at 570 nm with a
Wallac Victor II plate reader (Kingham et al. 2007).
Fibroblast-colony-forming unit assay
The fibroblast-colony-forming unit (CFU-F) assay was
performed as previously reported with minor modifications
(Wu et al. 2000; Vidal et al. 2007). Starting from a suspension
containing 103cells/ml, ASCs were plated by serial dilution in
6-well plates (from 48 cells/cm2 to 1 cell/cm2) and
cultured in control medium supplemented with 20% FBS.
At day 6, the medium was changed and, at day 10, cells
were fixed with 100% methanol and stained with 0.5%
crystal violet (Fluka, Buchs, Switzerland). The frequency
of the CFU-F was established by scoring individual
colonies (consisting of at least 20-30 cells) with respect
to the number of seeded cells.
Osteogenic differentiation and evaluation of differentiation
markers
ASCs were differentiated towards the osteogenic lineage by
using a specific inductive medium (OSTEO) supplemented
with 10 nM dexamethasone (Sigma-Aldrich), 10 mM
glycerol-2-phosphate (Sigma-Aldrich), 150 μM L-ascorbic
acid-2-phosphate (Sigma-Aldrich) and 10 nM cholecalcif-
erol (Sigma-Aldrich; de Girolamo et al. 2007, 2008).
Differentiation was performed in monolayer, cells being
seeded at a density of 5×103cells/cm2. Cells were cultured
at 37°C in a humidified atmosphere (5% CO2) for various
periods, the medium being changed three times a week.
Osteogenic differentiation of ASCs was assessed by
evaluating morphological changes, alkaline phosphatase
(ALP) activity, calcified extracellular matrix deposition
and specific bone protein expression.
ALP activity
In order to determine ALP activity, cells cultured for 7 and
14 days were washed with PBS and lysed in non-denaturant
conditions by using 0.1% Triton X-100 (Sigma-Aldrich) in
double-distilled H2O. ALP activity was determined by
incubating cellular lysates at 37°C in the presence of 1 mM
p-nitrophenylphosphate (Sigma-Aldrich) in alkaline buffer
(100 mM diethanolamine and 0.5 mM MgCl2, pH 10.5;
Bodo et al. 2002). The reaction was stopped with 1 N
NaOH and the absorbance of each sample was read at
410 nm with a Wallac Victor II plate reader. ALP activity
was then normalized to total protein content as determined
by BCA protein assay (Pierce Biotechnology, Rockford,
Ill., USA).
Calcified extracellular matrix deposition
After 7, 14 and 21 days of culture, extracellular matrix
mineral deposition was assessed by evaluating the presence
of red nodules stained by 40 mM alizarin red-S (AR-S,
pH 4.1; Fluka) after fixation in 70% ice-cold ethanol. The
quantification of mineral deposition was performed by
incubating the stained sample with 10% w/v cetylpyridi-
nium chloride (CPC; Sigma-Aldrich) in 0.1 M phosphate
buffer (pH 7.0) for 15 min to extract AR-S. Absorbance
was read at 550 nm with a Wallac Victor II plate reader
(Halvorsen et al. 2001).
Expression of bone-specific proteins
Osteocalcin and osteonectin protein expression was
evaluated by Western blot analysis in osteogenic-
differentiated ASCs. Cells incubated in CTRL or OSTEO
medium were detached from the dish, collected by
centrifugation and resuspended in lysis buffer (50 mM
TRIS pH 8, 150 mM NaCl, 1% Nonidet P40, 0.1% SDS)
supplemented with proteinase inhibitors. The protein con-
centration of cell lysates was analysed by a Pierce protein
assay kit (Pierce). Proteins (20 μg) were loaded onto 10%
SDS-polyacrylamide gels and electrotransferred onto
Hybond-ECL extra nitrocellulose membrane (Amersham
Bioscience). After being blocked in 5% nonfat dry milk in
TBS-T (TRIS-buffered saline and 0.1% Tween-20) for 1 h at
room temperature, membranes were incubated at 4°C
overnight with either rabbit anti-osteocalcin or mouse anti-
osteonectin (1:200 dilution; Santa Cruz Biotecnology, Santa
Cruz, Calif., USA) and mouse anti-β-actin (1:3000 dilution;
Sigma-Aldrich). Specific proteins were revealed by horse-
radish peroxidase (HRP)-conjugated secondary antibodies
(GE Healthcare) and the ECL Western Blotting Analysis
System Kit (GE Healthcare) according to the manufacturer’s
protocol. Osteocalcin and osteonectin expression was then
quantified by using ImageJ software. The osteo-specific
proteins content was normalized to that of β-actin.
The expression of osteocalcin and osteonectin was
also determined by immunofluorescence. ASCs differen-
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tiated for 28 days and cultured on coverslips were
washed with PBS+ (PBS supplemented with 0.1 mM
CaCl2 and 0.1 mM MgCl2) and fixed with 3% parafor-
maldehyde for 20 min. Autofluorescence was blocked
with 50 mM NH4Cl in PBS
+. The cells were permeabi-
lized for 4 min in PBS+ containing 0.1% Triton X-100 and
then incubated with rabbit anti-osteocalcin antibodies,
mouse anti-osteonectin antibodies, mouse anti-β-actin
antibodies or rabbit anti-β-tubulin antibodies (Santa Cruz
Biotecnology) for 60 min at room temperature. Specific
proteins were revealed by Alexa-Fluor-488 goat anti-
mouse antibodies and Alexa-Fluor-568 goat anti-rabbit
antibodies (Invitrogen, Camarillo, Calif., USA) for 30 min
at room temperature. Cover-slips were analysed by
confocal fluorescence microscopy (Bio-Rad MRC 1024;
Bio-Rad Laboratories, Hercules, Calif., USA).
ASCs-scaffold constructs
Undifferentiated rbASCs (5×104cells/scaffold) were loaded
onto clinical-grade porous (60%) HA granules (Permedica,
Merate, Italy and Biomaterials Research Center, University
of Milan, Italy) to evaluate their ability to grow and
differentiate in a 3D environment. Cells were allowed to
adhere overnight to scaffolds in microcentrifuge tubes and,
the following day, the seeded scaffolds were transferred to a
24-well plate and cultured for 14 and 21 days, either in
CTRL or OSTEO medium. ALP and calcium deposition
were analysed as described above.
Statistical analysis
Data are expressed as means±SD and statistical analysis
(two-way analysis of variance) was performed by using
GraphPad Prism v5.00 (GraphPad Software, San Diego,
Calif., USA): for OSTEO vs CTRL: *P<0.05, **P<0.01,
***P<0.001; for HA vs PA: $P<0.05, $$P<0.01, $$$P<0.001.
Results
Isolation and characterization of undifferentiated ASCs
Mesenchymal stem cells were isolated from adipose tissues
derived from three animal species and from various
anatomical sites: inguinal and perirenal adipose tissue from
rats, interscapular region from rabbits and caudal region
from pigs. We purified a consistent number of cells with an
average of 6.2×105±3.8×105 and 8.9×105±8.4×105 progen-
itor cells/ml raw adipose tissue from inguinal and perirenal
regions, respectively, of rats and 3.5×104±2.8×104 rbASC
cells were purified from each millilitre of rabbit interscap-
ular adipose tissue, whereas we isolated an average of
1.8×105±4.7×104cells/ml adipose tissue from porcine cau-
dal area (Fig. 1a). One week after isolation, ASCs started to
proliferate rapidly and, at passage 1, the variability of ASC
cell numbers, among the same different sites and species,
was reduced (Fig. 1a). All ASC cells showed a homoge-
neous fibroblast-like shape that was maintained for many
Fig. 1 a Cellular yield of ASCs
after isolation and at passage 1.
ASCs were isolated from
adipose tissue harvested from
various anatomical sites in rat
(rASCs), rabbit (rbASCs) and
pig (pASCs); n=3. b–d Micro-
photographs of undifferentiated
inguinal rASCs (b), rbASCs
(c) and pASCs (d) fixed at
passage 6 and stained with
haematoxylin-eosin (light
microscopy). Bar 100 µm
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passages in culture, without any signs of cellular aging
(Fig. 1b–d). These cells reached 80%-90% confluence
every 2-3 days: the doubling time (DT) was 74±19 h for
rASCs from inguinal adipose tissue and 93±27 h for
rASCs from the perirenal region (Fig. 2a). rbASCs grew
more rapidly with respect to rASCs and pASCs with a DT
of 46±12 h (Fig. 2b), whereas the DT of pASCs was
54±19 h (Fig. 2c). MTT assay confirmed that rbASCs and
pASCs possessed a greater ability for self-renewal than
rASCs (data not shown).
These ASCs showed a marked clonogenic ability.
Indeed, about 9.7% of inguinal rASCs and 7.4% of
perirenal rASCs were able to produce CFU-F at passage
1; this frequency gradually decreased during passages
(Fig. 3a). Surprisingly, at passage 1, rbASCs presented a
stronger clonogenic ability (about 23%), which slowly
decreased during culture, reaching a CFU-F value of 7% at
passage 4 (Fig. 3b). Interestingly, pASCs maintained a
high clonogenic potential without any significant differ-
ence between early and late passages (12%±6% for all
passages; Fig. 3b).
Osteogenic differentiation of ASCs
We next tested the osteogenic potential of ASCs derived
from the three different animal tissues by culturing rASCs,
rbASCs and pASCS in osteogenic medium for different
times. As early as 7 days in culture, all of the cells
exhibited some morphological modifications; indeed, cell
appearance changed from an elongated fibroblastic to a
more cuboidal shape (Arrigoni et al. 2009).
When the cells were induced to osteo-differentiate over
7 days, both inguinal and perirenal rASCs showed
abundant ALP activity compared with undifferentiated
cells, with an increase of about 56% for inguinal and 83%
for perirenal rASCs; this activity significantly increased
for both cellular populations after 14 days of osteogenic
differentiation (about +235% with respect to the undiffer-
entiated cells; Fig. 4a). Furthermore, both inguinal
(Fig. 4b, c) and perirenal differentiated cells produce a
greater amount of calcified extracellular matrix compared
with cells cultured in control medium. rASCs of both
origins, when differentiated for 7–21 days, were able to
produce high levels of calcium depots; however, these
increases were not statistically significant, since the
variability among samples was large (Fig. 4d).
In rbASCs, as early as 7 days of osteogenic
differentiation, ALP activity was significantly abundant
in osteo-differentiated cells in comparison with undif-
ferentiated cells, with an increase of about 148%.
Surprisingly, after 14 days in culture, ALP activity, for
both undifferentiated and differentiated cells, was higher
than that detected after 7 days (Fig. 4e). To confirm the
osteogenic differentiation ability of rbASCs, we quantified
the calcified extracellular matrix deposition after 7, 14 and
21 days of culture (Fig. 4f, g): osteo-induced cells
produced an abundant amount of calcified extracellular
matrix compared with undifferentiated cells, with an
increase of 22% and 50% after 7 and 14 days, respective-
ly. This increase was also maintained after 21 days of
differentiation (+43%; Fig. 4h).
pASCs that differentiated towards osteoblastic-like cells
showed an upregulation of ALP levels of 50% and 180% in
comparison with undifferentiated cells both after 7 and
14 days (Fig. 4i). Analysis of calcified extracellular matrix
deposition in differentiated pASCs for the same periods of
time showed increases in terms of calcified matrix
deposition of 45% and 30%, respectively, with a further
Fig. 2 Doubling time (DT) of rASCs (a), rbASCs (b) and pASCs (c)
at various passages in culture (n=3); DT=t×ln(2)/ln(N/N0), where t is
the time in culture (in hours), N is the final number of cells and N0 is
the initial number of cells (ING inguinal adipose tissue, REN perirenal
adipose tissue)
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increase (+22%) after 21 days of osteo-differentiation
(Fig. 4j–l).
In order to evaluate further the osteogenic differentiation
ability of rbASCs and pASCs, we examined osteocalcin
and osteonectin protein expression by Western blot
analysis and by immunofluorescence. Both osteo-induced
rbASCs and pASCs expressed osteocalcin and osteonec-
tin: these proteins were upregulated in osteogenic differ-
entiated rbASCs by about 152% and 51% and in pASCs
by 6% and 121%, with respect to undifferentiated cells,
respectively (Fig. 5a). Moreover, both osteocalcin
(Fig. 5d) and osteonectin (Fig. 5h, j) were expressed in
ASCs osteo-differentiated for 28 days but not in undiffer-
entiated cells (Fig. 5b, f). The expression of osteocalcin
and osteonectin was thus induced by the differentiation
process, although we observed that not all the cells were
homogeneously stained, in particular for the expression of
osteonectin, suggesting that differentiated rbASCs and
pASCs were not synchronized.
Furthermore, cryopreservation did not affect the stem
cell features or the osteogenic differentiation ability of
rASCs, rbASCs and pASC, as previously shown for hASCs
(de Girolamo et al. 2008).
Interaction of ASCs and HA scaffold
Since the final aim of our in vitro study was to test
cells suitable for future in vivo models, we needed to
check whether ASCs were able to adhere to scaffolds
routinely used in the orthopaedic field, such as HA
granules. rbASCs and pASCs tightly adhered to the
biomaterial and actively proliferated. Moreover, both
cell populations properly colonized the surface and the
pores of HA granules and no cellular toxicity was
produced by the scaffold (Fig. 6a; data not shown). Both
rbASCs and pASCs, seeded on HA and differentiated for
14 days, produced a 31% and 34% increase in ALP
activity compared with undifferentiated cells, respectively
(Fig. 6b, d). Then, when cultured in a 3D environment,
both undifferentiated rbASCs and pASCs showed greater
ALP activity in comparison with that of undifferentiated
cells cultured in monolayer (31% and 303%, respectively).
In addition, calcium depots, produced by rbASCs differ-
entiated for 21 days in the presence of HA, were
upregulated by 98% compared with cells maintained in
control medium (Fig. 6c). In contrast, pASCs induced to
differentiate in the presence of HA showed an increase of
Fig. 3 CFU-F assays performed with the ASCs at various passages in
culture. a, b Percentage of CFU-F cells was calculated as (number of
colonies/number of plated cells)×100. c–f Microphotographs of
colonies at passage 1 stained with crystal violet for inguinal (c) and
perirenal (d) rASCs, rbASCs (e) and pASCs (f)
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just about 20% in extracellular calcified matrix deposition
without a significant difference with respect to cells
cultured on plastic (Fig. 6e).
Discussion
In this study, we have compared the features of ASCs
isolated from rat, rabbit and pig, with particular reference to
their osteogenic differentiation potential.
In rat, the site of tissue harvesting seems to have little
effect on the characteristics of ASCs. Indeed, the number of
cells per millilitre of raw adipose tissue is higher from the
perirenal site than from the inguinal area. However, as early
as 1 week after isolation, we have observed a faster
proliferation rate of the cells derived from the inguinal
region with respect to those from the perirenal area, thereby
balancing the final cellular yield. In addition, the clono-
genic ability appears similar for both cell populations
showing a similar decrease during the passages in culture.
Fig. 4 Osteogenic differentiation assessment of rASCs (a-d), rbASCs
(e-h) and pASCs (i-l) (CTRL undifferentiated cells in control medium,
OSTEO differentiated cells in osteogenic medium, d days). a, e, i ALP
activity (means±SD of ALP U/µg proteins, n=3) for each species and
for various time points. b, c, f, g, j, k Microphotographs of alizarin
red-S staining at 21 days of culture for rASCs and at 21 days for
rbASCs and pASCs in control (b, f, j) and osteogenic (c, g, k)
medium (light microscopy). Bars 200 µm. d, h, l Quantification of
calcium deposition by cetylpyridinium chloride (CPC) extraction at
various time points (means±SD, n=3). OSTEO vs CTRL: *P<.05,
**P<.01, ***P<.001
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The number of ASCs from the interscapular rabbit
adipose tissue is significantly lower in comparison with
those from the rat and pig. However, as also demonstrated
by Peptan et al. (2006), rbASCs proliferate more rapidly
and show a marked clonogenic ability that mildly decreases
during passage, as also previously described for hASCs (de
Girolamo et al. 2008). Porcine adipose tissue contains an
abundant population of pASCs, showing a similar prolifer-
ative ability as the other animal ASCs but, interestingly,
these cells are better able to maintain their high clonogenic
potential throughout the period of culture that we have
analysed. Furthermore, all these ASCs have been tested
after cryopreservation and no differences have been
observed, suggesting their use for cell-based therapies,
even after a long period of time after their isolation (data
not shown).
All these cell types possess suitable osteogenic potential
as assessed by the upregulation of markers of osteogenic
differentiation such as ALP activity, osteocalcin and
osteonectin and as confirmed by the ability of these cells
to produce a large amount of calcified extracellular matrix.
Both rASC populations, if opportunely stimulated, acquire
some of the features of osteoblastic-like cells and, to date,
we have not determined any relevant difference that would
lead us to prefer one or the other cell population.
Our data demonstrate that osteo-differentiated rabbit
ASCs exhibit high levels of ALP activity just after 7 days
of differentiation, in contrast to results previously obtained
for hASCs and also reported by Peptan et al. (2006).
These observations might be useful in the perspective of
future in vivo applications because they suggest that the
time of ex vivo manipulation can be reduced before ASC
reimplantation.
In addition, the ability of these cells to adhere and grow
on an HA scaffold suggests that this biomaterial may be an
efficient support for future in vivo applications, even if HA
does not exert any significant osteoinductive effect on
rbASCs and pASCs differentiation,.
Before performing pilot clinical studies, the regenerative
capacity of human mesenchymal stem cells in both athymic
Fig. 5 Osteocalcin and osteonectin expression in undifferentiated and
osteogenically differentiated rbASCs and pASCs (CTRL undifferenti-
ated cells in control medium, OSTEO differentiated cells in osteogenic
medium). a Western blots. b–m Immunofluorescence analysis (light
microscopy). Osteocalcin expression (b, d). Osteonectin expression
(f, h, j, l). β-Actin (c, e) and β-tubulin (g, i, k, m) as housekeeping
proteins. Human osteosarcoma cells (SaOS-2) as positive controls
(l,m). Bars 100 μm
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and immune-competent pre-clinical animal models has to
be tested. However, although the nude model allows us to
test the in vivo behaviour of human-derived cells, it
presents limitations particularly because of the lack of the
immunological system, which is usually involved in every
regeneration process; this could delay the healing of any
experimental defects. Moreover, nude animals are more
prone to infections and systemic illness. Thus, these
disadvantages could mask the potential role of cells in the
healing process (Tholpady et al. 2003). Thus, immune-
competent animal models lacking these drawbacks might
better resemble the relevant biology in a clinical autologous
transplantation procedure.
Rabbits and pigs are promising animal models in the
field of regenerative medicine. In particular, rabbits are
useful for screening several experimental conditions be-
cause of their low cost of maintenance, whereas pigs
represent a more predictive model because of their greater
similarity to human beings with regard to diet, weight and
working load. The femoral defect in the rat also represents a
valid model in the orthopaedic field (Cuomo et al. 2009;
Smietana et al. 2009). However, we are interested in an
autologous cell-implant model, which we believe will not
be easy to obtain in rat. Moreover, the small dimension of
rat bones requires an extremely precise surgical approach,
which could be subjected to possible errors with resultant
effects on the final regeneration process.
Another important problem that researchers have to face
in isolating ASCs from these animals remains the lack of
reagents to evaluate specific mesenchymal stem cell
markers that might be partially overshadowed by the
similar morphological and biological features of both
rASCs, rbASCs and pASCs compared with human mesen-
chymal stem cells (Pittenger et al. 1999; Zuk et al. 2001).
In conclusion, our results could have relevant implica-
tions in the setting up of adequate bone regeneration
strategies based on the reimplantation of autologous ASCs
either in the undifferentiated or the pre-differentiated state.
We have just established an autologous rabbit model of
bone critical-size lesions by using ASCs in association with
disks of HA in order to assess the in vivo integration of the
cells/scaffold constructs with the surrounding bone tissue
and the effect of the physiological microenvironment
(experiments in progress). Adipose tissue represents a
precious source of multipotent cells with a great potential
for several clinical applications, above all in the field of the
Fig. 6 rbASCs (a) seeded on a hydroxyapatite scaffold cultured in
osteogenic medium (scanning electron microscopy). Bar 100 µm.
ALP activity of undifferentiated (CTRL) and osteo-differentiated
(OSTEO) rbASCs (b) and pASCs (d) cultured for 14 days both on
plastic (PA) and on hydroxyapatite (HA); means±SD of ALP U/µg
proteins, n=8. Calcified extracellular matrix deposition of undifferen-
tiated (CTRL) and osteo-differentiated (OSTEO) rbASCs (c) and
pASCs (e) cultured for 21 days on PA and in the presence of HAwere
quantified by CPC extraction; means±SD of CPC value/10^5 cells,
n=8. OSTEO vs CTRL: **P<0.01, ***P<0.001; HA vs PA: $$P<0.01,
$$$P<0.001
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regenerative medicine. We strongly believe that a large
animal model, such as the pig, has to be tested, before
moving on to a pilot clinical study.
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